Advanced search
Publication Cover
Hematology Volume 29, 2024 - Issue 1
Submit an article Journal homepage
822
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Sweet syndrome induced by FLT3 inhibitors: case report and literature review

Linhui Yanga Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People’s Republic of China
,
Ran Zhangb Department of Dermatology, West China Hospital of Sichuan University, Chengdu, People’s Republic of China
&
Hongbing Mac Department of Hematology, West China Hospital of Sichuan University, Chengdu, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1174-4078
ORCID Icon
Article: 2337230 | Received 05 Oct 2023, Accepted 26 Mar 2024, Published online: 02 Apr 2024

References

  • Cohen PR. Sweet's syndrome – a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:34. doi:10.1186/1750-1172-2-34
  • Raza S, Kirkland RS, Patel AA, et al. Insight into Sweet's syndrome and associated-malignancy: a review of the current literature. Int J Oncol. 2013;42:1516–1522. doi:10.3892/ijo.2013.1874
  • Burke N, Saikaly SK, Motaparthi K, et al. Malignancy-associated Sweet syndrome presenting with simultaneous histopathologic and morphologic variants. JAAD Case Rep. 2021;14:104–107. doi:10.1016/j.jdcr.2021.06.007
  • Martin S, Trenque T, Herlem E, et al. Drug-induced Sweet's syndrome: a case/noncase study in the French pharmacovigilance database. Br J Clin Pharmacol. 2023: 1–7. doi:10.1111/bcp.15873.
  • Nakao M, Yokota S, Iwai T, et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia. 1996;10:1911–1918.
  • Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome. J Am Acad Dermatol. 1996;34:943–923. doi:10.1016/S0190-9622(96)90269-8
  • Nelson CA, Stephen S, Ashchyan HJ, et al. Neutrophilic dermatoses: pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Behçet disease. J Am Acad Dermatol. 2018;79:987–1006. doi:10.1016/j.jaad.2017.11.064
  • Radomska HS, Bassères DS, Zheng R, et al. Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J Exp Med. 2006;203:371–381. doi:10.1084/jem.20052242
  • Alkassis S, Rizwan A, Daoud L, et al. Midostaurin-induced Sweet syndrome in a patient with FLT3-ITD-positive AML. BMJ Case Rep. 2021;14:e243615.
  • Fathi AT, Stein EM, DiNardo CD, et al. Differentiation syndrome with lower-intensity treatments for acute myeloid leukemia. Am J Hematol. 2021;96:735–746. doi:10.1002/ajh.26142
  • Norsworthy KJ, Mulkey F, Scott EC, et al. Differentiation syndrome with ivosidenib and enasidenib treatment in patients with relapsed or refractory IDH-mutated AML: A U.S. food and drug administration systematic analysis. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. 2020;26:4280–4288. doi:10.1158/1078-0432.CCR-20-0834
  • Fathi AT, Le L, Hasserjian RP, et al. FLT3 inhibitor-induced neutrophilic dermatosis. Blood. 2013;122:239–242.
  • Varadarajan N, Boni A, Elder DE, et al. Flt3 inhibitor-associated neutrophilic dermatoses. JAMA Dermatol. 2016;152:480–482.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.